nach oben

Erschienen in:

25.10.2023 | Trabekulektomie | Leitthema

Real-world-Ergebnisse von glaukomchirurgischen Verfahren beim Offenwinkelglaukom

verfasst von: Alicja Strzalkowska, Esther M. Hoffmann, Piotr Strzalkowski, Julia V. Stingl, Norbert Pfeiffer, Alexander K. Schuster

Erschienen in: Die Ophthalmologie | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Zusammenfassung

Diese Arbeit bietet einen Überblick über Real-world-Ergebnisse bei glaukomchirurgischen Verfahren. Obwohl randomisierte klinische Studien wichtige Erkenntnisse liefern, spiegeln sie nicht das reale Versorgungsgeschehen wider. Real-world-Studien ermöglichen eine Beurteilung der Ergebnisse außerhalb kontrollierter Settings und sind für die Beratung und Entscheidungsfindung bei Glaukombehandlung von großer Bedeutung. Durch die Untersuchung von Real-world-Daten zielt die Arbeit darauf ab, seltene unerwünschte Ereignisse zu identifizieren, die in kontrollierten klinischen Studien möglicherweise übersehen werden. Der Fokus liegt darauf, die Wirksamkeit und Sicherheit von glaukomchirurgischen Verfahren über das kontrollierte Studiensetting hinaus zu bewerten.

Holz FG, Tadayoni R, Beatty S, Berger A, Cereda MG, Cortez R et al (2015) Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration. Br J Ophthalmol 99:220–226PubMedCrossRef

Wolfram C, Schuster AK (2022) Glaucoma care in Germany-results of a survey among German ophthalmologists-part 2: treatment. Ophthalmologie 119:1140–1148PubMedCrossRef

Saheb H, Ahmed IIK (2012) Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol 23:96–104PubMedCrossRef

Jordan JF, Wecker T, van Oterendorp C, Anton A, Reinhard T, Boehringer D et al (2013) Trabectome surgery for primary and secondary open angle glaucomas. Graefes Arch Clin Exp Ophthalmol 251:2753–2760PubMedPubMedCentralCrossRef

Akil H, Chopra V, Huang A, Loewen N, Noguchi J, Francis BA (2016) Clinical results of ab interno trabeculotomy using the Trabectome in patients with pigmentary glaucoma compared to primary open angle glaucoma. Clin Experiment Ophthalmol 44:563–569PubMedCrossRef

Ting JLM, Damji KF, Stiles MC, Trabectome Study Group (2012) Ab interno trabeculectomy: outcomes in exfoliation versus primary open-angle glaucoma. J Cataract Refract Surg 38:315–323PubMedCrossRef

Strzalkowska A, Strzalkowski P, Al Yousef Y, Grehn F, Hillenkamp J, Loewen NA (2021) Exact matching of trabectome-mediated ab interno trabeculectomy to conventional trabeculectomy with mitomycin C followed for 2 years. Graefes Arch Clin Exp Ophthalmol 259:963–970PubMedCrossRef

Jea SY, Francis BA, Vakili G, Filippopoulos T, Rhee DJ (2012) Ab interno trabeculectomy versus trabeculectomy for open-angle glaucoma. Ophthalmology 119:36–42PubMedCrossRef

Kornmann HL, Fellman RL, Feuer WJ, Butler MR, Godfrey DG, Smith OU et al (2019) Early results of goniotomy with the Kahook dual blade, a novel device for the treatment of glaucoma. Clin Ophthalmol 13:2369–2376PubMedPubMedCentralCrossRef

10.

Sieck EG, Epstein RS, Kennedy JB, SooHoo JR, Pantcheva MB, Patnaik JL et al (2018) Outcomes of Kahook dual blade Goniotomy with and without phacoemulsification cataract extraction. Ophthalmol Glaucoma 1:75–81PubMedCrossRef

11.

Shue A, Levine RM, Gallousis GM, Teng CC (2019) Cyclodialysis cleft associated with Kahook dual blade goniotomy. J Curr Glaucoma Pract 13:74–76PubMedPubMedCentralCrossRef

12.

Guedes RAP, Gravina DM, Lake JC, Guedes VMP, Chaoubah A (2019) Intermediate results of iStent or iStent inject implantation combined with cataract surgery in a real-world setting: a longitudinal retrospective study. Ophthalmol Ther 8:87–100PubMedPubMedCentralCrossRef

13.

Klamann MKJ, Gonnermann J, Pahlitzsch M, Maier A‑KB, Joussen AM, Torun N et al (2015) iStent inject in phakic open angle glaucoma. Graefes Arch Clin Exp Ophthalmol 253:941–947PubMedCrossRef

14.

Bicket AK, Le JT, Azuara-Blanco A, Gazzard G, Wormald R, Bunce C et al (2021) Minimally invasive glaucoma surgical techniques for open-angle glaucoma: an overview of Cochrane systematic reviews and network meta-analysis. JAMA Ophthalmol 139:983–989PubMedCrossRef

15.

Grierson I, Saheb H, Kahook MY, Johnstone MA, Ahmed IIK, Schieber AT et al (2015) A novel Schlemm’s canal scaffold: histologic observations. J Glaucoma 24:460–468PubMedCrossRef

16.

Jabłońska J, Lewczuk K, Rękas MT (2023) Comparison of safety and efficacy of Hydrus and iStent combined with phacoemulsyfication in open angle glaucoma patients: 24-month follow-up. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph20054152CrossRefPubMedPubMedCentral

17.

Salimi A, Kassem R, Santhakumaran S, Harasymowycz P (2023) Three-year outcomes of a Schlemm canal microstent (Hydrus Microstent) with concomitant phacoemulsification in open-angle glaucoma. Ophthalmol Glaucoma 6:137–146PubMedCrossRef

18.

Pfeiffer N, Garcia-Feijoo J, Martinez-de-la-Casa JM, Larrosa JM, Fea A, Lemij H et al (2015) A randomized trial of a Schlemm’s canal microstent with phacoemulsification for reducing intraocular pressure in open-angle glaucoma. Ophthalmology 122:1283–1293PubMedCrossRef

19.

Loayza-Gamboa W, Martel-Ramirez V, Inga-Condezo V, Valderrama-Albino V, Alvarado-Villacorta R, Valera-Cornejo D (2020) Outcomes of combined prolene gonioscopy assisted transluminal trabeculotomy with phacoemulsification in open-angle glaucoma. Clin Ophthalmol 14:3009–3016PubMedPubMedCentralCrossRef

20.

Cubuk MO, Ucgul AY, Unsal E (2020) Gonioscopy-assisted transluminal trabeculotomy as an option after failed trabeculectomy. Int Ophthalmol 40:1923–1930PubMedCrossRef

21.

Sharkawi E, Lindegger DJ, Artes PH, Lehmann-Clarke L, El Wardani M, Misteli M et al (2021) Outcomes of gonioscopy-assisted transluminal trabeculotomy in pseudoexfoliative glaucoma: 24-month follow-up. Br J Ophthalmol 105:977–982PubMedCrossRef

22.

Guo C‑Y, Qi X‑H, Qi J‑M (2020) Systematic review and Meta-analysis of treating open angle glaucoma with gonioscopy-assisted transluminal trabeculotomy. Int J Ophthalmol 13:317–324PubMedPubMedCentralCrossRef

23.

Grover DS, Flynn WJ, Bashford KP, Lewis RA, Duh Y‑J, Nangia RS et al (2017) Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol 183:25–36PubMedCrossRef

24.

Reitsamer H, Sng C, Vera V, Lenzhofer M, Barton K, Stalmans I et al (2019) Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 257:983–996PubMedCrossRef

25.

Mansouri K, Bravetti GE, Gillmann K, Rao HL, Ch’ng TW, Mermoud A (2019) Two-year outcomes of XEN gel Stent surgery in patients with open-angle glaucoma. Ophthalmol Glaucoma 2:309–318PubMedCrossRef

26.

Gillmann K, Bravetti GE, Rao HL, Mermoud A, Mansouri K (2021) Combined and stand-alone XEN 45 gel stent implantation: 3‑year outcomes and success predictors. Acta Ophthalmol 99:e531–e539PubMedCrossRef

27.

Lenzhofer M, Kersten-Gomez I, Sheybani A, Gulamhusein H, Strohmaier C, Hohensinn M et al (2019) Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-centre study. Clinical Exper Ophthalmology. https://doi.org/10.1111/ceo.13463CrossRef

28.

Rauchegger T, Angermann R, Willeit P, Schmid E, Teuchner B (2021) Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma. Acta Ophthalmol 99:369–375PubMedCrossRef

29.

Sng CC, Wang J, Hau S, Htoon HM, Barton K (2018) XEN-45 collagen implant for the treatment of uveitic glaucoma. Clin Experiment Ophthalmol 46:339–345PubMedCrossRef

30.

Bormann C, Schmidt M, Busch C, Rehak M, Scharenberg CT, Unterlauft JD (2022) Implantation of XEN after failed trabeculectomy: an efficient therapy? Klin Monbl Augenheilkd 239:86–93PubMedCrossRef

31.

Buffault J, Graber M, Bensmail D, Bluwol É, Jeanteur M‑N, Abitbol O et al (2020) Efficacy and safety at 6 months of the XEN implant for the management of open angle glaucoma. Sci Rep 10:4527PubMedPubMedCentralCrossRef

32.

Gupta C, Mathews D (2019) XEN® stent complications: a case series. BMC Ophthalmol 19:253PubMedPubMedCentralCrossRef

33.

Karri B, Gupta C, Mathews D (2018) Endophthalmitis following XEN stent exposure. J Glaucoma 27:931–933PubMedCrossRef

34.

Theilig T, Rehak M, Busch C, Bormann C, Schargus M, Unterlauft JD (2020) Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study. Sci Rep 10:19337PubMedPubMedCentralCrossRef

35.

Cappelli F, Cutolo CA, Olivari S, Testa V, Sindaco D, Pizzorno C et al (2022) Trabeculectomy versus Xen gel implant for the treatment of open-angle glaucoma: a 3-year retrospective analysis. BMJ Open Ophthalmol 7:e830PubMedPubMedCentralCrossRef

36.

Baker ND, Barnebey HS, Moster MR, Stiles MC, Vold SD, Khatana AK et al (2021) Ab-externo microshunt versus trabeculectomy in primary open-angle glaucoma: one-year results from a 2-year randomized, multicenter study. Ophthalmology 128:1710–1721PubMedCrossRef

37.

Pawiroredjo SSM, Bramer WM, Pawiroredjo ND, Pals J, Poelman HJ, de Vries VA et al (2022) Efficacy of the PRESERFLO microshunt and a meta-analysis of the literature. J Clin Med Res. https://doi.org/10.3390/jcm11237149CrossRef

38.

Fea AM, Laffi GL, Martini E, Economou MA, Caselgrandi P, Sacchi M et al (2022) Effectiveness of microshunt in patients with primary open-angle and pseudoexfoliative glaucoma: a retrospective European multicenter study. Ophthalmol Glaucoma 5:210–218PubMedCrossRef

39.

Quaranta L, Micheletti E, Carassa R, Bruttini C, Fausto R, Katsanos A et al (2021) Efficacy and safety of PreserFlo® microshunt after a failed trabeculectomy in eyes with primary open-angle glaucoma: a retrospective study. Adv Ther 38:4403–4412PubMedPubMedCentralCrossRef

40.

Micheletti E, Riva I, Bruttini C, Quaranta L (2020) A case of delayed-onset hemorrhagic choroidal detachment after PreserFlo Microshunt implantation in a glaucoma patient under anticoagulant therapy. J Glaucoma 29:e87–e90PubMedCrossRef

41.

Brambati M, Bettin P, Ramoni A, Battista M, Bandello F (2022) A case of endophthalmitis following needling procedure after PRESERFLO® Micro Shunt implantation. Eur J Ophthalmol 32:NP83–NP86PubMedCrossRef

42.

Jamke M, Herber R, Haase MA, Jasper CS (2023) PRESERFLO^TM MicroShunt versus trabeculectomy: 1‑year results on efficacy and safety. Graefes Arch Clin Exp Ophthalmol. https://doi.org/10.1007/s00417-023-06075-4CrossRefPubMedPubMedCentral

43.

Wagner FM, Schuster AK, Munder A, Muehl M, Chronopoulos P, Pfeiffer N et al (2022) Comparison of subconjunctival microinvasive glaucoma surgery and trabeculectomy. Acta Ophthalmol 100:e1120–e1126PubMedCrossRef

44.

Kuet M‑L, Azuara-Blanco A, Barton K, King AJ (2022) Will the PRESERFLO^TM MicroShunt impact the future of trabeculectomy practice? A UK and Éire Glaucoma Society National Survey. Eye. https://doi.org/10.1038/s41433-022-02326-6CrossRefPubMedPubMedCentral

45.

Stingl JV, Wagner FM, Liebezeit S, Baumgartner R, Spät H, Schuster AK et al (2023) Long-term efficacy and safety of modified canaloplasty versus trabeculectomy in open-angle glaucoma. Life. https://doi.org/10.3390/life13020516CrossRefPubMedPubMedCentral

46.

Nassri L, Plange N, Lindemann F, Schellhase H, Walter P, Kuerten D (2020) Therapieerfolg von Kanaloplastik und Trabekulektomie durch denselben Operateur mit demselben Erfahrungslevel im Langzeitverlauf. Ophthalmologe 117:1025–1032PubMedCrossRef

47.

Grieshaber MC, Pienaar A, Olivier J, Stegmann R (2010) Canaloplasty for primary open-angle glaucoma: long-term outcome. Br J Ophthalmol 94:1478–1482PubMedCrossRef

48.

Seuthe A‑M, Ivanescu C, Leers S, Boden K, Januschowski K, Szurman P (2016) Modified canaloplasty with suprachoroidal drainage versus conventional canaloplasty-1-year results. Arbeitsphysiologie 254:1591–1597

49.

Gesser C, Wiermann A, Keserü M, Richard G, Klemm M (2014) Long-term follow-up after deep sclerectomy. Klin Monbl Augenheilkd 231:535–539PubMed

50.

Shaarawy T, Mansouri K, Schnyder C, Ravinet E, Achache F, Mermoud A (2004) Long-term results of deep sclerectomy with collagen implant. J Cataract Refract Surg 30:1225–1231PubMedCrossRef

51.

Schuster AK, Uhrig M, Pfeiffer N, Hoffmann EM (2022) Wie lernt man eine Trabekulektomie operieren? Die Ophthalmol 119:1006–1016CrossRef

52.

Landers J, Martin K, Sarkies N, Bourne R, Watson P (2012) A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology 119:694–702PubMedCrossRef

53.

Wagner FM, Schuster AK, Kianusch K, Stingl J, Pfeiffer N, Hoffmann EM (2023) Long-term success after trabeculectomy in open-angle glaucoma: results of a retrospective cohort study. BMJ Open 13:e68403PubMedPubMedCentralCrossRef

54.

Chen PP (2003) Blindness in patients with treated open-angle glaucoma. Ophthalmology 110:726–733PubMedCrossRef

55.

Singh J, O’Brien C, Chawla HB (1995) Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery. Eye 9(Pt 4):460–466PubMedCrossRef

56.

Edmunds B, Thompson JR, Salmon JF, Wormald RP (2002) The National Survey of Trabeculectomy. III. Early and late complications. Eye 16:297–303PubMedCrossRef

57.

Feiner L, Piltz-Seymour JR (2003) Collaborative Initial Glaucoma Treatment Study: a summary of results to date. Curr Opin Ophthalmol 14:106–111PubMedCrossRef

58.

Montesano G, Ometto G, King A, Garway-Heath DF, Crabb DP (2023) Two-year visual field outcomes of the treatment of advanced glaucoma study (TAGS). Am J Ophthalmol 246:42–50PubMedCrossRef

59.

Weber C, Hundertmark S, Brinken R, Holz FG, Mercieca K (2022) Erste klinische Ergebnisse mit dem PAUL®-Glaukom-Implantat an der Universitäts-Augenklinik Bonn. Ophthalmologie 119:1267–1274PubMedCrossRef

60.

Goulet RJ 3rd, A‑DT P, Cantor LB, WuDunn D (2008) Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant. Ophthalmology 115:1141–1147PubMedCrossRef

61.

Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL (2009) Three-year-follow-up of the tube versus Trabeculectomy study. Am J Ophthalmol 148(5):670–684PubMedCrossRef

62.

Godinho G, Barbosa-Breda J, Oliveira-Ferreira C, Madeira C, Melo A, Falcão-Reis F et al (2021) Anterior chamber versus ciliary Sulcus Ahmed glaucoma valve tube placement: longitudinal evaluation of corneal endothelial cell profiles. J Glaucoma 30:170–174PubMedCrossRef

63.

Iwasaki K, Arimura S, Takihara Y, Takamura Y, Inatani M (2018) Prospective cohort study of corneal endothelial cell loss after Baerveldt glaucoma implantation. PLoS ONE 13:e201342PubMedPubMedCentralCrossRef

64.

José P, Barão RC, Teixeira FJ, Marques RE, Peschiera R, Barata A et al (2022) One-year efficacy and safety of the PAUL glaucoma implant using a standardized surgical protocol. J Glaucoma 31:201–205PubMedCrossRef

65.

Tan MCJ, Choy HYC, Koh Teck CV, Aquino MC, Sng CCA, Lim DKA et al (2022) Two-year outcomes of the Paul glaucoma implant for treatment of glaucoma. J Glaucoma 31:449–455PubMedPubMedCentralCrossRef

66.

Wang S, Gao X, Qian N (2016) The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a meta-analysis. BMC Ophthalmol 16:83PubMedPubMedCentralCrossRef

67.

Hoffmann EM, Hengerer F, Klabe K, Schargus M, Thieme H, Voykov B (2021) Glaucoma surgery today. Ophthalmologe 118:239–247PubMedCrossRef

68.

Samuelson TW, Sarkisian SR Jr, Lubeck DM, Stiles MC, Duh Y‑J, Romo EA et al (2019) Prospective, randomized, controlled pivotal trial of an Ab Interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results. Ophthalmology 126:811–821PubMedCrossRef

Titel: Real-world-Ergebnisse von glaukomchirurgischen Verfahren beim Offenwinkelglaukom
verfasst von: Alicja Strzalkowska
Esther M. Hoffmann
Piotr Strzalkowski
Julia V. Stingl
Norbert Pfeiffer
Alexander K. Schuster
Publikationsdatum: 25.10.2023
Verlag: Springer Medizin
Schlagwörter: Trabekulektomie
Glaukom
Trabekulotomie
Erschienen in: Die Ophthalmologie / Ausgabe 11/2023
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI: https://doi.org/10.1007/s00347-023-01941-2

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Real-world-Ergebnisse von glaukomchirurgischen Verfahren beim Offenwinkelglaukom

Zusammenfassung

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2023

Bewusstsein für eine Glaukomerkrankung in der Bevölkerung

Epidemiologische Auswirkungen der COVID-19-Pandemie auf Enukleationsfälle in Deutschland

„Dome-shaped maculopathy“ bei einem 11-jährigen Kind

Anwendung von Antiglaukomatosa in der urbanen erwachsenen Bevölkerung

Rebound-Tonometrie mit sterilisierten Sonden

Nichtarteriitische anteriore ischämische Optikusneuropathie (nAION)

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde